<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rpmj</journal-id><journal-title-group><journal-title xml:lang="ru">Research'n Practical Medicine Journal</journal-title><trans-title-group xml:lang="en"><trans-title>Research and Practical Medicine Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2410-1893</issn><publisher><publisher-name>"QUASAR", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17709/2409-2231-2020-7-4-4</article-id><article-id custom-type="elpub" pub-id-type="custom">rpmj-631</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи. Онкология, лучевая терапия</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Articles. Оncology</subject></subj-group></article-categories><title-group><article-title>Качественная и количественная характеристика разных типов опухолевых микрососудов в зависимости от гистологического типа рака шейки матки</article-title><trans-title-group xml:lang="en"><trans-title>Qualitative and quantitative characteristics of different types of tumor microvessels depending on the histological type of cervical cancer</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8371-740X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сеньчукова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Senchukova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сеньчукова Марина Алексеевна – д.м.н., профессор кафедры лучевой диагностики, лучевой терапии, онкологии, врач-онколог хирургического торакального отделения</p><p>460000, г. Оренбург, ул. Советская, д. 6</p><p>460021, г. Оренбург, просп. Гагарина, д. 11 </p><p>SPIN: 9877-8828</p><p>AuthorID: 583884</p><p>Scopus Author ID: 56084387100</p><p>ResearcherID: W-6584-2018</p></bio><bio xml:lang="en"><p>Marina A. Senchukova – Dr. Sci. (Med.), professor of the radiation diagnostics, radiation therapy, oncology department, physician -oncologist of the surgical thoracic department</p><p>6 Sovetskaya str., Orenburg, 460000</p><p>11 Gagarin ave., Orenburg, 460021</p><p>SPIN: 9877-8828</p><p>AuthorID: 583884</p><p>Scopus Author ID: 56084387100</p><p>ResearcherID: W-6584-2018</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5796-3719</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макарова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Макарова Елена Викторовна – аспирант кафедры лучевой диагностики, лучевой терапии, онкологии, врач отделения ультразвуковой диагностики </p><p>460000, г. Оренбург, ул. Советская, д. 6</p><p>460021, г. Оренбург, просп. Гагарина, д. 11 </p></bio><bio xml:lang="en"><p>Elena V. Makarova – PhD student of the radiation diagnostics, radiation therapy, oncology department, doctor of the department of ultrasound</p><p>6 Sovetskaya str., Orenburg, 460000</p><p>11 Gagarin ave., Orenburg, 460021</p></bio><email xlink:type="simple">malena2419@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0571-2803</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шурыгина</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Shurygina</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шурыгина Елена Ивановна – ассистент кафедры патологической анатомии, врач патологоанатомического отделения</p><p>460000, г. Оренбург, ул. Советская, д. 6</p><p>460021, г. Оренбург, просп. Гагарина, д. 11 </p></bio><bio xml:lang="en"><p>Elena I. Shurygina – department of pathology, physician at the department of pathology</p><p>6 Sovetskaya str., Orenburg, 460000</p><p>11 Gagarin ave., Orenburg, 460021</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4873-4455</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волченко</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Volchenko</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Волченко Надежда Николаевна – д.м.н., профессор, заведующая отделом онкоморфологии</p><p>125284, г. Москва, 2-й Боткинский проезд, д. 3</p><p>AuthorID: 290657</p></bio><bio xml:lang="en"><p>Nadezhda N. Volchenko – Dr. Sci. (Med.), professor, head of the tumor morphology department</p><p>3 2nd Botkinskiy travel, Moscow, 125284</p><p>AuthorID: 290657</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Оренбургский государственный медицинский университет» Министерства здравоохранения Российской Федерации; ГБУЗ «Оренбургский областной клинический онкологический диспансер»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Orenburg State Medical University; Orenburg Regional Clinical Oncology Dispensary</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>МНИОИ им. П.А.Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>P.A.Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>21</day><month>12</month><year>2020</year></pub-date><volume>7</volume><issue>4</issue><fpage>36</fpage><lpage>50</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сеньчукова М.А., Макарова Е.В., Шурыгина Е.И., Волченко Н.Н., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Сеньчукова М.А., Макарова Е.В., Шурыгина Е.И., Волченко Н.Н.</copyright-holder><copyright-holder xml:lang="en">Senchukova M.A., Makarova E.V., Shurygina E.I., Volchenko N.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpmj.ru/rpmj/article/view/631">https://www.rpmj.ru/rpmj/article/view/631</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Дать качественную и количественную оценку разным типам опухолевых микрососудов в зависимости от гистологического типа рака шейки матки (РШМ).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Объектом исследования служили образцы опухоли 76 пациенток с РШМ I–IIА стадии, получивших первым этапом хирургическое лечение. Иммуногистохимическое исследование проведено с использованием антител к CD34 и подопланину. Статистическую обработку результатов исследования выполняли с использованием программы Statistica 6.0.</p></sec><sec><title>Результаты</title><p>Результаты. При РШМ выделены следующие типы опухолевых микрососудов: обычные микрососуды, дилятированные капилляры (ДК) c обычной эндотелиальной выстилкой, ДК со слабо выраженной экспрессией CD34, ДК контактного типа, капилляры в солидном компоненте опухоли, атипичные дилятированные капилляры (АДК), структуры с частичной эндотелиальной выстилкой, лимфатические капилляры в лимфоидных и полиморфноклеточных инфильтратах. Установлено, что с прогнозом заболевания при раннем РШМ коррелировали ДК со слабовыраженной экспрессией CD34 (р=0,0005), ДК контактного типа (р=0,000005) и капилляры в солидном компоненте опухоли (р=0,006). Частота выявления этих типов опухолевых микрососудов, была ниже при прогностически благоприятном плоскоклеточном неороговевающем РШМ, тогда как для прогностически неблагоприятных плоскоклеточном ороговевающем РШМ и аденокарциноме шейки матки были характерны более высокие значения ДК со слабовыраженной экспрессией CD34 (р=0,004 и р=0,005, соответственно) и ДК контактного типа (р=0,02 и р=0,14, соответственно).</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose of the study</title><p>Purpose of the study. To give a qualitative and quantitative assessment of different types of tumor microvessels depending on the histological type of cervical cancer (CC).</p></sec><sec><title>Material and methods</title><p>Material and methods. The tumor samples from 76 patients with CC stage I–IIA who received the surgical treatment on the first phase were the object of study. The immunohistochemical study was performed using antibodies to CD34 and podoplanin. Statistical analysis of the data was performed using the Statistica 6.0 software.</p></sec><sec><title>Results</title><p>Results. In CC, the following types of tumor microvessels have been identified: normal microvessels, dilated capillaries (DCs) with a normal endothelial lining, DCs with a weak expression of CD34, DCs of contact type, capillaries in the solid component of tumor, the atypical dilated capillaries (ADCs), the structures with partial endothelial lining and the lymphatic capillaries in lymphoid and polymorphic cell infiltrates. It was found that DCs with a mild expression of CD34 (p=0.0005), DCs of contact type (p=0.000005), and capillaries in the solid component of tumor (p=0.006) were correlated with the prognosis in early CC. The detection frequency of this tumor microvessels was lower in more prognostically favorable squamous non-keratinizing CC, while in the prognostically unfavorable squamous cell keratinizing CC and adenocarcinoma of the cervix uteri, the higher DCs values with a mild expression of CD34 (р=0,004 and р=0.005, respectively) and DC of contact type (p=0.02 and p=0.14, respectively) were typical.</p></sec><sec><title>Conclusion</title><p>Conclusion. We consider it is expedient to further study the relationship of different types of tumor microvessels with clinical and morphological characteristics and prognosis of cervical cancer.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>рак шейки матки</kwd><kwd>аденокарцинома</kwd><kwd>плоскоклеточный рак</kwd><kwd>ангиогенез</kwd><kwd>опухолевые микрососуды</kwd><kwd>прогноз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cervical cancer</kwd><kwd>adenocarcinoma</kwd><kwd>squamous cervical cancer</kwd><kwd>angiogenesis</kwd><kwd>tumor microvessels</kwd><kwd>prognosis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при финансовой поддержке РФФИ и Субъекта РФ в рамках научных проектов № 18-415-560005 и №19-415-560004.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–e203. https://doi.org/10.1016/S2214-109X(19)30482-6</mixed-citation><mixed-citation xml:lang="en">Arbyn M., Weiderpass E., Bruni L., de Sanjosé S., Saraiya M., Ferlay J. et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020 Feb;8(2):e191-e203. https://doi.org/10.1016/S2214-109X(19)30482-6.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Состояние онкологической помощи населению России в 2016 году. Под ред. А.Д.Каприна, В.В.Старинского, Г.В.Петровой. М.: МНИОИ им. П.А.Герцена – филиал ФГБУ «НМИРЦ радиологии» Минздрава России, 2017, 236 с.</mixed-citation><mixed-citation xml:lang="en">Sostoyanie onkologicheskoj pomoshchi naseleniyuRossii v 2018 godu. [The status of cancer care for the population of Russia in 2018]. Ed by Kaprin A.D., Starinskiy V.V., Petrovа G.V. Moscow: MNII them. P.A. Herzen branch of the FSBI "NIIRTS" Ministry of Health of Russia. 2019. p.236. ISBN 978-5-85502-250-6(In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Журман В.Н., Елисеева Е.В., Гулевич А.П., Слободенюк Е.В. Социально-экономические последствия смертности женщин от злокачественных новообразований женских половых органов. Дальневосточный медицинский журнал. 2016;(1):89–91.</mixed-citation><mixed-citation xml:lang="en">Zhurman VN, Eliseevа EV, Gulevich AP, Slobodenyuk EV. Socio-economic effects of women mortality from female genitals malignant tumors. Far East Medical Journal. 2016(1):89-91. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Гатагажева З.М., Дикке Г.Б., Узденова З.Х., Цаллагова Л.В., Зеленова О.В., Мисирова М.М. и др. Организационные и экономические аспекты оптимизации программы скрининга рака шейки матки в Республике Ингушетия. Вопросы гинекологии, акушерства и перинатологии. 2020;19(1):151– 157. https://doi.org/10.20953/1726-1678-2020-1-151-157</mixed-citation><mixed-citation xml:lang="en">Gatagazheva ZМ, Dikke GB, Uzdenova ZKh, Tsallagova LV, Zelenova ОV, Мisirova ММ. Organizational and economic aspects of optimization of a cervical cancer screening programme in the Republic of Ingushetia. Gynecology, Obstetricsand Perinatology. 2020;19(1):151–157. (In Russian). https://doi.org/10.20953/1726-1678-2020-1-151-157</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kubota S, Kobayashi E, Kakuda M, Matsuzaki S, Ueda Y, Yoshino K, et al. Retrospective analysis for predictors of parametrial involvement in IB cervical cancer. J Obstet Gynaecol Res. 2019 Mar;45(3):679–685. https://doi.org/10.1111/jog.13855</mixed-citation><mixed-citation xml:lang="en">Kubota S, Kobayashi E, Kakuda M, Matsuzaki S, Ueda Y, Yoshino K, et al. Retrospective analysis for predictors of parametrial involvement in IB cervical cancer. J Obstet Gynaecol Res. 2019 Mar;45(3):679–685. https://doi.org/10.1111/jog.13855</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuo K, Shimada M, Saito T, Takehara K, Tokunaga H, Watanabe Y, et al. Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB-IIB cervical cancer. J Gynecol Oncol. 2018 Jan;29(1):e11. https://doi.org/10.3802/jgo.2018.29.e11</mixed-citation><mixed-citation xml:lang="en">Matsuo K, Shimada M, Saito T, Takehara K, Tokunaga H, Watanabe Y, et al. Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB-IIB cervical cancer. J Gynecol Oncol. 2018 Jan;29(1):e11. https://doi.org/10.3802/jgo.2018.29.e11</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Machida H, Matsuo K, Furusawa A, Kita T, Kitagawa R, Mikami M. Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan. PLoS One. 2019;14(1):e0210125. https://doi.org/10.1371/journal.pone.0210125</mixed-citation><mixed-citation xml:lang="en">Machida H, Matsuo K, Furusawa A, Kita T, Kitagawa R, Mikami M. Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan. PLoS One. 2019;14(1):e0210125. https://doi.org/10.1371/journal.pone.0210125</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Tsuchida K, Murakami N, Kato T, Okuma K, Okamoto H, Kashihara T, et al. Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients. J Radiat Res. 2019 Oct 23;60(5):650–657. https://doi.org/10.1093/jrr/rrz041</mixed-citation><mixed-citation xml:lang="en">Tsuchida K, Murakami N, Kato T, Okuma K, Okamoto H, Kashihara T, et al. Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients. J Radiat Res. 2019 Oct 23;60(5):650–657. https://doi.org/10.1093/jrr/rrz041</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Гуськова Е.А., Неродо Г.А., Гуськова Н.К., Порываев Ю.A., Черникова Н.В. Факторы, влияющие на частоту рецидивирования рака шейки матки. Международный журнал прикладных и фундаментальных исследований. 2015;(10-1):87–91.</mixed-citation><mixed-citation xml:lang="en">Guskova EA, Nerodo GA, Guskova NK, Poryvaev YA, Chernikova NV. Factors influencing the frequency of recurrence of cervical cancer. International Journal of Applied and Fundamental Research. 2015;10(1):87-91. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Anfinan N, Sait K. Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia. Ann Saudi Med. 2020 Feb;40(1):25–35. https://doi.org/10.5144/0256-4947.2020.25</mixed-citation><mixed-citation xml:lang="en">Anfinan N, Sait K. Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia. Ann Saudi Med. 2020 Feb;40(1):25–35. https://doi.org/10.5144/0256-4947.2020.25</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tang M, Liu Q, Yang X, Chen L, Yu J, Qi X, et al. Perineural invasion as a prognostic risk factor in patients with early cervical cancer. Oncol Lett. 2019 Jan;17(1):1101–1107. https://doi.org/10.3892/ol.2018.9674</mixed-citation><mixed-citation xml:lang="en">Tang M, Liu Q, Yang X, Chen L, Yu J, Qi X, et al. Perineural invasion as a prognostic risk factor in patients with early cervical cancer. Oncol Lett. 2019 Jan;17(1):1101–1107. https://doi.org/10.3892/ol.2018.9674</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bishop AJ, Allen PK, Klopp AH, Meyer LA, Eifel PJ. Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated? Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):196–205. https://doi.org/10.1016/j.ijrobp.2014.09.023</mixed-citation><mixed-citation xml:lang="en">Bishop AJ, Allen PK, Klopp AH, Meyer LA, Eifel PJ. Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated? Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):196–205. https://doi.org/10.1016/j.ijrobp.2014.09.023</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Чуруксаева О.Н., Коломиец Л.А., Ибрагимова М.К., Литвяков Н.В. Особенности папилломавирусной инфекции высокого канцерогенного риска у больных местно-распространенным раком шейки матки. Вопросы гинекологии, акушерства и перинатологии. 2019;18(3):21–28. https://doi.org/10.20953/1726-1678-2019-3-21-28</mixed-citation><mixed-citation xml:lang="en">Churuksaeva ON, Kolomiets LA, Ibragimova МK, Litvyakov NV. Specificities of high-risk papillomavirus infection in patients with locally advanced cervical cancer. Gynecology, Obstetrics and Perinatology. 2019;18(3):21–28. (In Russian). https://doi.org/10.20953/1726-1678-2019-3-21-28</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Cao L, Wen H, Feng Z, Han X, Wu X. Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer. Int J Gynecol Cancer. 2019;29(8):1244–1251. https://doi.org/10.1136/ijgc-2019-000556</mixed-citation><mixed-citation xml:lang="en">Cao L, Wen H, Feng Z, Han X, Wu X. Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer. Int J Gynecol Cancer. 2019;29(8):1244– 1251. https://doi.org/10.1136/ijgc-2019-000556</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bean LM, Ward KK, Plaxe SC, McHale MT. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery. Am J Obstet Gynecol. 2017;217(3):332. e1–332.e6. https://doi.org/10.1016/j.ajog.2017.05.021</mixed-citation><mixed-citation xml:lang="en">Bean LM, Ward KK, Plaxe SC, McHale MT. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery. Am J Obstet Gynecol. 2017;217(3):332. e1–332.e6. https://doi.org/10.1016/j.ajog.2017.05.021</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gadducci A, Guerrieri ME, Cosio S. Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables. Crit Rev Oncol Hematol. 2019 Mar;135:103–114. https://doi.org/10.1016/j.critrevonc.2019.01.006</mixed-citation><mixed-citation xml:lang="en">Gadducci A, Guerrieri ME, Cosio S. Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables. Crit Rev Oncol Hematol. 2019 Mar;135:103–114. https://doi.org/10.1016/j.critrevonc.2019.01.006</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992 Jun 5;267(16):10931–10934 18. Bielenberg DR, Zetter BR. The Contribution of Angiogenesis to the Process of Metastasis. Cancer J. 2015 Aug;21(4):267–273. https://doi.org/10.1097/PPO.0000000000000138</mixed-citation><mixed-citation xml:lang="en">Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992 Jun 5;267(16):10931–10934</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Hu X, Liu H, Ye M, Zhu X. Prognostic value of microvessel density in cervical cancer. Cancer Cell Int. 2018;18:152. https://doi.org/10.1186/s12935-018-0647-3</mixed-citation><mixed-citation xml:lang="en">Bielenberg DR, Zetter BR. The Contribution of Angiogenesis to the Process of Metastasis. Cancer J. 2015 Aug;21(4):267–273. https://doi.org/10.1097/PPO.0000000000000138</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">A Y, Li Y, Zhao S. The expression and underlying angiogenesis effect of DPC4 and VEGF on the progression of cervical carcinoma. Oncol Lett. 2018 Feb;15(2):2534–2540. https://doi.org/10.3892/ol.2017.7580</mixed-citation><mixed-citation xml:lang="en">Hu X, Liu H, Ye M, Zhu X. Prognostic value of microvessel density in cervical cancer. Cancer Cell Int. 2018;18:152. https://doi.org/10.1186/s12935-018-0647-3</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Nagy JA, Chang S-H, Shih S-C, Dvorak AM, Dvorak HF. Heterogeneity of the tumor vasculature. Semin Thromb Hemost. 2010 Apr;36(3):321–31. https://doi.org/10.1055/s-0030-1253454</mixed-citation><mixed-citation xml:lang="en">A Y, Li Y, Zhao S. The expression and underlying angiogenesis effect of DPC4 and VEGF on the progression of cervical carcinoma. Oncol Lett. 2018 Feb;15(2):2534–2540. https://doi.org/10.3892/ol.2017.7580</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Castro PR, Barbosa AS, Pereira JM, Ranfley H, Felipetto M, Gonçalves CAX, et al. Cellular and Molecular Heterogeneity Associated with Vessel Formation Processes. Biomed Res Int. 2018;2018:6740408. https://doi.org/10.1155/2018/6740408</mixed-citation><mixed-citation xml:lang="en">Nagy JA, Chang S-H, Shih S-C, Dvorak AM, Dvorak HF. Heterogeneity of the tumor vasculature. Semin Thromb Hemost. 2010 Apr;36(3):321–31. https://doi.org/10.1055/s-0030-1253454</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Senchukova M, Kiselevsky MV. The “Cavitary” Type of Angiogenesis by Gastric Cancer. Morphological Characteristics and Prognostic Value. J Cancer. 2014 Mar 20;5(5):311–319. https://doi.org/10.7150/jca.8716</mixed-citation><mixed-citation xml:lang="en">Castro PR, Barbosa AS, Pereira JM, Ranfley H, Felipetto M, Gonçalves CAX, et al. Cellular and Molecular Heterogeneity Associated with Vessel Formation Processes. Biomed Res Int. 2018;2018:6740408. https://doi.org/10.1155/2018/6740408</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Senchukova MA, Nikitenko NV, Tomchuk ON, Zaitsev NV, Stadnikov AA. Different types of tumor vessels in breast cancer: morphology and clinical value. Springerplus. 2015;4:512. https://doi.org/10.1186/s40064-015-1293-z</mixed-citation><mixed-citation xml:lang="en">Senchukova M, Kiselevsky MV. The "Cavitary" Type of Angiogenesis by Gastric Cancer. Morphological Characteristics and Prognostic Value. J Cancer. 2014 Mar 20;5(5):311–319. https://doi.org/10.7150/jca.8716</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Senchukova MA, Makarova EV, Shurygina EI, Volchenko NN. Morphological Characteristics and Clinical Significance of Different Types of Tumor Vessels in Patients with Stages I-IIA of Squamous Cervical Cancer. J Oncol. 2020;2020:3818051. https://doi.org/10.1155/2020/3818051</mixed-citation><mixed-citation xml:lang="en">Senchukova MA, Nikitenko NV, Tomchuk ON, Zaitsev NV, Stadnikov AA. Different types of tumor vessels in breast cancer: morphology and clinical value. Springerplus. 2015;4:512. https://doi.org/10.1186/s40064-015-1293-z</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Goddard JC, Sutton CD, Furness PN, Kockelbergh RC, O’Byrne KJ. A computer image analysis system for microvessel density measurement in solid tumours. Angiogenesis. 2002;5(1-2):15–20. https://doi.org/10.1023/a:1021518315757</mixed-citation><mixed-citation xml:lang="en">Senchukova MA, Makarova EV, Shurygina EI, Volchenko NN. Morphological Characteristics and Clinical Significance of Different Types of Tumor Vessels in Patients with Stages I-IIA of Squamous Cervical Cancer. J Oncol. 2020;2020:3818051. https://doi.org/10.1155/2020/3818051</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">McCluggage WG. Towards developing a meaningful grading system for cervical squamous cell carcinoma. J Pathol Clin Res. 2018 Apr;4(2):81–85. https://doi.org/10.1002/cjp2.98</mixed-citation><mixed-citation xml:lang="en">Goddard JC, Sutton CD, Furness PN, Kockelbergh RC, O’Byrne KJ. A computer image analysis system for microvessel density measurement in solid tumours. Angiogenesis. 2002;5(1-2):15–20. https://doi.org/10.1023/a:1021518315757</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Yamada T, Ishihara S, Kawai M, Itoh Y, Naganawa S, Ikeda M. Analysis of late adverse events and their chronological changes after radiation therapy for cervical cancer. Nagoya J Med Sci. 2018 Nov;80(4):487–496. https://doi.org/10.18999/nagjms.80.4.487</mixed-citation><mixed-citation xml:lang="en">McCluggage WG. Towards developing a meaningful grading system for cervical squamous cell carcinoma. J Pathol Clin Res. 2018 Apr;4(2):81–85. https://doi.org/10.1002/cjp2.98</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Yamada T, Ishihara S, Kawai M, Itoh Y, Naganawa S, Ikeda M. Analysis of late adverse events and their chronological changes after radiation therapy for cervical cancer. Nagoya J Med Sci. 2018 Nov;80(4):487–496. https://doi.org/10.18999/nagjms.80.4.487</mixed-citation><mixed-citation xml:lang="en">Yamada T, Ishihara S, Kawai M, Itoh Y, Naganawa S, Ikeda M. Analysis of late adverse events and their chronological changes after radiation therapy for cervical cancer. Nagoya J Med Sci. 2018 Nov;80(4):487–496. https://doi.org/10.18999/nagjms.80.4.487</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
